TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.48, sa.5, ss.933-938, 2018 (SCI-Expanded)
Background/aim: Management of atopic dermatitis (AD) in children is still challenging. The aim of this study was to evaluate the efficacy and safety profile of cyclosporine-A (CsA) treatment in children with severe and recalcitrant AD.